Form 4: Pfizer Executive Douglas Lankler Modifies Stock Appreciation Rights
SEC Form 4
Executive Vice President Douglas M. Lankler reports changes in beneficial ownership of Pfizer stock appreciation rights due to a modification offer.
Summary
- Douglas M. Lankler, an Executive Vice President at Pfizer Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- The changes are due to a one-time offer by Pfizer to modify certain outstanding stock appreciation rights (TSRUs).
- Lankler elected to modify Eligible TSRUs to extend the dates upon which the awards vest and settle by two years.
- The grant price and number of shares underlying the Modified TSRUs remain unchanged.
- The transactions occurred on September 12, 2024.
- Lankler modified TSRUs with grant prices of $42.3, $45.96 and $46.94.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a routine executive compensation adjustment.
Future Outlook
The document does not contain specific forward-looking statements beyond the modification of the TSRUs.
Industry Context
This filing is a routine disclosure related to executive compensation and is specific to Pfizer's internal policies regarding stock appreciation rights.
Stakeholder Impact
- The modification of TSRUs may have a minor impact on shareholder equity, but the overall effect is likely insignificant.
Key Dates
| Date | Description |
|---|---|
| August 12, 2024 | Pfizer filed a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission regarding the Modification Offer. |
| September 12, 2024 | Date of the transaction where Douglas M. Lankler modified his stock appreciation rights. |
| September 16, 2024 | Date of the Form 4 filing. |
| February 23, 2027 | Original expiration date of some of the Stock Appreciation Rights before modification. |
| February 24, 2027 | Original expiration date of some of the Stock Appreciation Rights before modification. |
| February 28, 2027 | Original expiration date of some of the Stock Appreciation Rights before modification. |
| February 23, 2028 | Original expiration date of some of the Stock Appreciation Rights before modification. |
| February 23, 2029 | New expiration date of some of the Stock Appreciation Rights after modification. |
| February 24, 2029 | New expiration date of some of the Stock Appreciation Rights after modification. |
| February 28, 2029 | New expiration date of some of the Stock Appreciation Rights after modification. |
| February 23, 2030 | New expiration date of some of the Stock Appreciation Rights after modification. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.